Bristol-Myers Squibb 1Q11 1Q Revenues: $5.0 billion (+4%) 1Q Earnings: $986 million (+33%) Comments: U.S. sales were up 5% to $3.3 billion in the quarter. International sales increased 3% to $1.8 billion (1% excluding foreign exchange impact). Plavix sales were up 6% to $1.8 billion. Sustiva Franchise sales were $343 million (+2%). Baraclude sales were $275 million (+27%). Sprycel sales were up 31% to $172 million. Orencia sales were up 18% to $199 million. Abilify sales were $624 milli...